Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

1(50.0%)

Phase 4

1(50.0%)

2Total

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04704050Phase 4Terminated

Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence

Role: collaborator

NCT04703166Recruiting

Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

Role: collaborator

NCT02391987Not ApplicableCompleted

Integrated Tele-monitoring and Patient-centric Health Coaching Strategy in Patients Hospitalized With Heart Failure

Role: collaborator

NCT01975402Completed

Evaluation of the BodyGuardian End-to-end Remote Monitoring Platform in an Outpatient Heart Failure Population

Role: collaborator

NCT02255526Completed

BodyGuardian Respiration and Activity Validation Testing

Role: lead

NCT01808053Completed

Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects

Role: collaborator

All 6 trials loaded